Vemurafenib (VM) in non-melanoma V600 and non-V600 BRAF mutated cancers: first results of the ACSE trial

Book of the 41st ESMO Congress (ESMO 2016) Copenhagen, Denmark, 7–11 October 2016 Institut Universitaire du Cancer -ToulouseOncopole : 7 Institut Claudius-Regaud : 11 CHU Toulouse Larrey : 10 CHU Toulouse, Rangueil : 4 Dont 2 en communs